Vishva M. Dixit, M.D. is Vice President of Physiological Chemistry at Genentech, Inc. in South San Francisco, CA. His interests include cell death, NF-kB signaling, role of ubiquitin modification in disease pathogenesis, and characterizing regulatory complexes within the innate immune system, especially, the Inflammasome.
A historical perspective of his contributions is documented in three accounts published in Nature (2008, 453:271-273), Nature Cell Biology (2010, 12(5): 415) and The Journal of Immunology (2013, 190:3-4).
He is a Foreign Member, European Molecular Biology Organization, a member of the National Academy of Medicine, the American Academy of Arts and Sciences and the National Academy of Sciences.